Judge allows subpoena on Plan B documents
A US Magistrate Judge ruled in November that the Center for Reproductive Rights can subpoena White House documents as part of its lawsuit against the Food and Drug Administration. The center is pursuing a lawsuit to ensure that Plan B is made widely available over the counter to women of all ages. (In August 2006, the FDA approved Plan B without a prescription, but only for women 18 years and older and only behind the pharmacy counter.)
A US Magistrate Judge ruled in November that the Center for Reproductive Rights can subpoena White House documents as part of its lawsuit against the Food and Drug Administration. The center is pursuing a lawsuit to ensure that Plan B is made widely available over the counter to women of all ages. (In August 2006, the FDA approved Plan B without a prescription, but only for women 18 years and older and only behind the pharmacy counter.)
The judge granted the request after finding that the FDA demonstrated "a strong showing of bad faith" in its decision-making process around Plan B. In the ruling, the judge cited several pieces of information that seemed to reflect the FDA's improper behavior, including:
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
